1. Plasma metabolites, metabolic risk score and colorectal cancer risk: a prospective cohort study, European Journal of Epidemiology, 2025, 40(12): 1455-1468.

2. Identification and validation of blood leukocyte DNA methylation biomarkers for early detection of colorectal neoplasm, Chinese Medical Journal, 2025.

3. Bone morphogenetic protein 1 as a macromolecular pan-cancer biomarker modulating the immune microenvironment and malignant phenotypes in glioblastoma, International Journal of Biological Macromolecules, 2025, 331(Pt 1): 148136.

4. Plasma metabolites, systolic blood pressure, lifestyle, and stroke risk: A prospective cohort study.Int J Stroke 2025 Apr;20(4):486-496.

5. Identification and validation of DNA methylation-driven gene PCDHB4 as a novel tumor suppressor for glioblastoma diagnosis and prognosis, Molecular Carcinogenesis, 2023, 62(12): 1832-1845.